Picture of Krka dd Novo Mesto logo

KRKG Krka dd Novo Mesto Share Price

0.000.00%
si flag iconLast trade - 00:00
HealthcareConservativeLarge CapSuper Stock

Momentum

Relative Strength (%)
1m+0.3%
3m+2.66%
6m+3.52%
1yr+3.04%
Volume Change (%)
10d/3m+7.26%
Price vs... (%)
52w High-5.34%
50d MA+1.2%
200d MA+9.86%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)11.32
PEG Ratio (f)1.96
EPS Growth (f)6.12%
Dividend Yield (f)5.75%
Valuation (ttm)IndustryMarket
Price to Book Value1.77
Price to Tang. Book1.86
Price to Free Cashflow43.49
Price to Sales2.12
EV to EBITDA6.7

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital17.14%
Return on Equity14.67%
Operating Margin22.12%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total Revenue€m1,493.411,534.941,565.81,717.451,806.391,874.381,955.566.28%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+46.77+16.54+7.29+17.2-13.21+6.79+4.52n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Krka dd Novo Mesto EPS forecast chart

Profile Summary

Krka dd Novo Mesto is a Slovenia-based company engaged in the production of pharmaceutical preparations. The Company operates through four segments: Prescription Pharmaceuticals that includes medicines for the treatment of cardiovascular diseases, alimentary tract and metabolism and drugs for diseases of the central nervous system, among others; Non-prescription Products, providing vitamins and minerals, cough and cold products, analgesics, sore throat products, among others; Animal Health Products, which offers general anti-infectives and antiparasitics for animals; Health Resort and Tourist Services consisting of Spa resorts in Smarjeske Toplice, Dolenjske Toplice, Strunjan, Novo Mesto and Otocec. Krka dd Novo Mesto is a controlling company of the Krka Group that includes two subsidiaries in Slovenia, Terme Krka doo and Farma GRS doo, and over 20 subsidiaries abroad in such countries as Croatia, Germany, Sweden, Poland, Spain, United States, Ireland, among others.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
July 13th, 1989
Public Since
February 10th, 1997
No. of Shareholders
47,172
No. of Employees
11,667
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
si flag iconLjubljana Stock Exchange
Shares in Issue
30,877,482

KRKG Share Price Performance

Upcoming Events for KRKG

Q1 2024 Krka dd Novo Mesto Earnings Release

Krka dd Novo Mesto Annual Shareholders Meeting

Krka dd Novo Mesto Annual Shareholders Meeting

Q2 2024 Krka dd Novo Mesto Earnings Release

FAQ